The Heterogeneous Distribution of Monosomy 3 in Uveal Melanomas: Implications for Prognostication Based on Fine-Needle Aspiration Biopsies

Autor: Willem, Maat, Ekaterina S, Jordanova, Shama L, van Zelderen-Bhola, Ed R, Barthen, Hans W, Wessels, Nicoline E, Schalij-Delfos, Martine J, Jager

Publikováno v: Archives of Pathology and Laboratory Medicine, 131(1), 91-96. College of American Pathologists

Context.—The detection of monosomy 3 in uveal melanomas has repeatedly been associated with adverse outcome. Fine-needle aspiration biopsy is being used to detect monosomy 3 in these tumors, based on the assumption that this chromosomal abnormality

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c65e273ab4581e8b921388a332a01e4
https://doi.org/10.5858/2007-131-91-thdomi

A novel t(6;14)(q25∼q27;q32) in acute myelocytic leukemia involves the BCL11B gene

Autor: Antoinette A. T. P. Brink, Shama L. van Zelderen-Bhola, G. C. Beverstock, Carla Rosenberg, Renee M.Y. Barge, Karoly Szuhai, Anton K. Raap, Vladimir Bezrookove

Publikováno v: Bezrookove, V, Van Zelderen-Bhola, S L, Brink, A, Szuhai, K, Raap, A K, Barge, R, Beverstock, G C & Rosenberg, C 2004, ' A novel t(6;14)(q25∼q27;q32) in acute myelocytic leukemia involves the BCL11B gene ', Cancer Genetics and Cytogenetics, vol. 149, no. 1, pp. 72-76 . https://doi.org/10.1016/S0165-4608(03)00302-9
Cancer Genetics and Cytogenetics, 149(1), 72-76. Elsevier Inc.

Cytogenetic studies in a patient with acute myelocytic leukemia (AML) revealed as the sole karyotypic alteration a half-cryptic rearrangement, identified with 48-color combined binary ratio-labeled fluorescence in situ hybridization (pq-COBRA-FISH) a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5b4d19d0665235847548a2206ba9be1
https://doi.org/10.1016/s0165-4608(03)00302-9

The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses

Autor: Hanneke C. Kluin-Nelemans, Shama L. van Zelderen-Bhola, Menno A. W. G. van der Hoorn, J.H. Frederik Falkenburg, Roel Willemze, Rolf E. Brouwer

Publikováno v: Brouwer, R E, Van Der Hoorn, M, Kluin-Nelemans, H C, Van Zelderen-Bhola, S, Willemze, R & Falkenburg, J H F 2000, ' The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses ', Human Immunology, vol. 61, no. 6, pp. 565-574 . https://doi.org/10.1016/S0198-8859(00)00111-7
Human Immunology, 61(6), 565-574. Elsevier Inc.

To increase the immunogenicity of leukemic cells, attempts were made to generate dendritic-like antigen presenting cells (DC) from AML blasts from 14 patients with AML FAB classifications M0-M5. Leukemic cells were cultured in the presence or absence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::683391c9cc92cd1b461ccec3bb66af04
https://doi.org/10.1016/s0198-8859(00)00111-7

Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia

Autor: Peter J. M. Valk, Edo Vellenga, Eva van den Berg-de Ruiter, Heinz A. Horst, Sabine Kayser, Shama L. van Zelderen-Bhola, Konstanze Döhner, Hartmut Döhner, Matthias Theobald, Augustin Ferrant, Michael Pfreundschuh, H. Berna Beverloo, Ruud Delwel, Gert J. Ossenkoppele, Thomas Pabst, Urs Schanz, Martine Jotterand, Stefan Gröschel, Marie von Lilienfeld-Toal, Jürgen Krauter, Arnold Ganser, Gregor Verhoef, Elisabeth Koller, Brigitte Schlegelberger, Sanne Lugthart, Peter Vandenberghe, Claus-Henning Köhne, Martin Bentz, Richard F. Schlenk, Bob Löwenberg

Publikováno v: Journal of Clinical Oncology, 28(24), 3890-3898. American Society of Clinical Oncology
Journal of Clinical Oncology, 28(24), 3890-3898. AMER SOC CLINICAL ONCOLOGY
Lugthart, S, Groschel, S, Beverloo, HB, Kayser, S, Valk, P J M, Van Zelderen-Bhola, S L, Ossenkoppele, G J, Vellenga, E, van den Berg-de Ruiter, E, Schanz, U, Verhoef, G, Vandenberghe, P, Ferrant, A, Koohne, C H, Pfreundschuh, M, Horst, H A, Koller, E, von Lilienfeld-Toal, M, Bentz, M, Ganser, A, Schlegelberger, B, Jotterand, M, Krauter, J, Pabst, T, Theobald, M, Schlenk, R F, Delwel, R, Doohner, K, Lowenberg, B & Dohner, H 2010, ' Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia ', Journal of Clinical Oncology, vol. 28, no. 24, pp. 3890-3898 . https://doi.org/10.1200/JCO.2010.29.2771

Purpose Acute myeloid leukemia (AML) with inv(3)(q21q26.2)/t(3;3)(q21;q26.2) [inv(3)/t(3;3)] is recognized as a distinctive entity in the WHO classification. Risk assignment and clinical and genetic characterization of AML with chromosome 3q abnormal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936e44befa645bb23ae36b208512ad73
https://research.vumc.nl/en/publications/26290cb1-9105-44ce-b375-3481c7671aec

Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions

Autor: Eva van den Berg, Shama L. van Zelderen-Bhola, Eugenia Haralambieva, Jeroen E. J. Guikema, Clemens Mellink, Henry Wabinga, King H. Lam, Ed Schuuring, Inge M. Appel, Luiz Fernando Bleggi-Torres, Stefano Rosati, Patty M. Jansen, Philip M. Kluin, Carel J. M. van Noesel

Publikováno v: Genes, chromosomes & cancer, 40(1), 10-18. Wiley-Liss Inc.
Haralambieva, E, Schuuring, E, Rosati, S, Van Noesel, C, Jansen, P, Appel, I, Guikema, J, Wabinga, H, Bleggi-Torres, L F, Lam, K, Van Den Berg, E, Mellink, C, Van Zelderen-Bhola, S & Kluin, P 2004, ' Interphase Fluorescence In Situ Hybridization for Detection of 8q24/MYC Breakpoints on Routine Histologic Sections : Validation in Burkitt Lymphomas from Three Geographic Regions ', Genes Chromosomes and Cancer, vol. 40, no. 1, pp. 10-18 . https://doi.org/10.1002/gcc.20009
Genes Chromosomes and Cancer, 40(1), 10-18
Genes Chromosomes & Cancer, 40, 10-18. Wiley-Liss Inc.

A chromosomal translocation involving the MYC gene is characteristic of Burkitt lymphoma (BL) and represents a molecular disease marker with diagnostic and clinical implications. The detection of MYC breakpoints is hampered by technical problems, inc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d11f2c21ba3c806e194bce915be893d
https://pure.amc.nl/en/publications/interphase-fluorescence-in-situ-hybridization-for-detection-of-8q24myc-breakpoints-on-routine-histologic-sections-validation-in-burkitt-lymphomas-from-three-geographic-regions(5932dde2-1f61-470c-9fd1-6f544b134529).html